03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Volmax 8mg* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Abela Freres |
Distributor | Abela Freres |
Laboratory | GSK |
Responsible Party | Glaxo Operations UK Ltd |
Origin | UK |
Manufacturer | Glaxo Operations Ltd |
Origin | UK |
ATC | R03AC02 |
Volmax 8mg* :
Volmax 8mg* :
Volmax 8mg* :
Volmax 8mg* :
Volmax 8mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
Arrhythmia | Rare |
Atrial fibrillation | Rare |
Bronchospasm | Very rare |
Collapse | Very rare |
Extrasystoles | Rare |
Headache | Common |
Hyperactivity (Increased activity) | Very rare |
Hypersensitivity reactions | Very rare |
Hypokalaemia | Rare |
Hypotension | Very rare |
Muscle cramps | Common |
Muscle tension | Very rare |
Myocardial ischaemia | Not known |
Palpitations | Common |
Peripheral vasodilatation (Peripheral vasculitis) | Rare |
Supraventricular tachycardia | Rare |
Tachycardia | Common |
Tremor | Very Common |
Urticaria | Very rare |
Volmax 8mg* :
NB : Products With Same Indication |
Different Units By MoH Code
Volmax 8mg* MoH 616 :
Form | Tablet |
Package Size | Box of 14 |
Strength | 8mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 27017 |
Submission date | 01/01/1991 |
Registration Year | 1991 |
Archived Date | 2014 |
Price Comparison
● Country: | Abu Dhabi | |
● Package Size: | 14 | |
● Public Price: | 21.5 AED | ( 519,461.50 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 1,5357 AED | ( 24,161.00 LBP ) |
● Pharmacy Price: | 17.39 AED | ( 420159.79 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 14's | |
● Public Price: | 21.5 AED | ( 519,461.50 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 1,5357 AED | ( 24,161.00 LBP ) |
● Pharmacy Price: | 17.39 AED | ( 420159.79 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File